Juliana Piedade

Juliana Piedade

Auto-generated profile, based on publicly available information

Juliana Piedade

Gastroenterology and Hepatology Unit, Bonsucesso Federal Hospital, Ministry of Health, Rio de Janeiro 22640-100, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
FFFlavia F Fernandes
Flavia F Fernandes
JPJuliana Piedade
Juliana Piedade
LGLivia Guimaraes
Livia Guimaraes
ENEstevao P Nunes
Estevao P Nunes
UCUrsula B Chaves
Ursula B Chaves
HPHugo Perazzo
Hugo Perazzo

1 January 2020 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GPGustavo Pereira
Gustavo Pereira
CBCaroline Baldin
Caroline Baldin
JPJuliana Piedade
Juliana Piedade
VRVanessa Reis
Vanessa Reis
TVTatiana Valdeolivas
Tatiana Valdeolivas
JPJoão Luiz Pereira
João Luiz Pereira

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
ABAriane Borgonovo
Ariane Borgonovo
CBCaroline Baldin
Caroline Baldin
DMDariana C. Maggi
Dariana C. Maggi
LVLivia Victor
Livia Victor
EBEmilia T. O. Bansho
Emilia T. O. Bansho
LSLeonardo L. Schiavon
Leonardo L. Schiavon
Background. Although recently challenged, systemic inflammatory response syndrome (SIRS) criteria are still commonly used in daily practice to define sepsis. However, several factors in liver cirrhosis may negatively impact its prognostic ability. Goals. To investigate the factors associated with the presence of SIRS, the characteristics of SIRS related to infection, and its prognostic value among patients hospitalized for acute decompensation of cirrhosis. Study. In this cohort study from two tertiary hospitals, 543 patients were followed up, up to 90 days. Data collection, including the prognostic models, was within 48 hours of admission. Results. SIRS was present in 42.7% of the sample and was independently associated with upper gastrointestinal bleeding (UGB), ACLF, infection, and negatively related to beta‐blockers. SIRS was associated with mortality in univariate analysis, but not in multiple Cox regression analysis. The Kaplan–Meier survival probability of patients without SIRS was 73.0% and for those with SIRS was 64.7%. The presence of SIRS was not significantly associated with mortality when considering patients with or without infection, separately. Infection in SIRS patients was independently associated with Child‐Pugh C and inversely related to UGB. Among subjects with SIRS, mortality was independently related to the presence of infection, ACLF, and Child‐Pugh C. Conclusions. SIRS was common in hospitalized patients with cirrhosis and was of no prognostic value, even in the presence of infection.

Verified
Journal Article
Open access
PDF file
ZVZulane S. T. Veiga
Zulane S. T. Veiga
FFFlávia F. Fernandes
Flávia F. Fernandes
LGLívia Guimarães
Lívia Guimarães
JPJuliana Piedade
Juliana Piedade
GPGustavo Pereira
Gustavo Pereira
Background: Hepatosplenic schistosomiasis (HSS) is a peculiar form of non-cirrhotic portal hypertension (NCPH). Although HSS patients present normal hepatic function, some evolve signs of hepatocellular failure and features of decompensated cirrhosis. The natural history of HSS-NCPH is unknown. Methods: A retrospective study was conducted that evaluated patients who fulfilled clinical-laboratorial criteria for HSS. Results: A total of 105 patients were included. Eleven patients already presented with decompensated disease and had lower transplant-free survival at 5 years than those without (61% vs. 95%, p = 0.015). Among 94 patients without prior decompensation, the median follow-up was 62 months and 44% of them had varicose bleeding (two or more episodes in 27%). Twenty-one patients presented at least one episode of decompensation (10-year probability 38%). Upon multivariate analysis, varicose bleeding and higher bilirubin levels were associated with decompensation. The 10-year probability of survival was 87%. Development of decompensation and age were predictive of mortality. Conclusion: HSS is characterized by multiple episodes of GI bleeding, a high probability of decompensation and reduced survival at the end of the first decade. Decompensation is more common in patients with varicose esophageal bleeding and is associated with lower survival.

1 September 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
HPHugo Perazzo
Hugo Perazzo
JPJuliana Piedade
Juliana Piedade
RCRodolfo Castro
Rodolfo Castro
LPLaura Pinto
Laura Pinto
VVValdiléa G. Veloso
Valdiléa G. Veloso
FFFlavia F. Fernandes
Flavia F. Fernandes

24 July 2020 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
EFElio C. Castro Filho
Elio C. Castro Filho
JPJuliana Piedade
Juliana Piedade
RCRodolfo Castro
Rodolfo Castro
PLPaula M. Luz
Paula M. Luz
FFFlavia Fernandes
Flavia Fernandes
HPHugo Perazzo
Hugo Perazzo